Yili Chuanning Biotechnology Co.,Ltd.

¥8.07As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301301Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (1.03%)
Div yield 2.14%
ROE 6.05%
Biotechnology
Beta (5Y) 0.12
PE TTM 36.65
TSR TTM (27.93%)
Mkt cap ¥18.01B
ROIC 6.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.76
20.96%
(56.54%)
Hold 3|11|12|11|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.14
0.15
0.16
18.61%
9.61%
10.01%
6.67%
Revenue¥M
795.3
815.3
813.5
814.5
5.56%
4.22%
1.28%
(0.09%)
Peers (US$2.700B)
Cap (US$)
PE
2.722B
—
2.709B
—
Capital
TTM
5Y
10Y
Leveragex
3.465
(0.135)
(0.086)
EBIT/Intx
0.242
0.378
0.355
Own earn%
119.53
24.68
21.97
Sh yield%
20.52
25.29
32.00
Owners
Insiders/Inst%
8.92
89.05
Short interest%
1.73
SBC / revenue%
1.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
19–28
$1 testx
−0.1
Incr. ROIC%
5